Hyperproduction of polyhedrin-IGF II fusion protein in silkworm larvae infected with recombinant Bombyx mori nuclear polyhedrosis virus. 1987

Y Marumoto, and Y Sato, and H Fujiwara, and K Sakano, and Y Saeki, and M Agata, and M Furusawa, and S Maeda
Research Institute, Daiichi Seiyaku Co. Ltd., Tokyo, Japan.

A gene coding for insulin-like growth factor II (IGF II) was constructed from 16 oligodeoxynucleotides synthesized chemically and cloned into EcoRI-SalI sites of pBR322. In this gene at ATG codon for methionine was introduced for cleavage by CNBr at the beginning of mature IGF II. For expressing foreign genes, a new host-vector system, with Bombyx mori silkworm larvae as the host and B. mori nuclear polyhedrosis virus (BmNPV) as the vector, has been developed. BmNPV genomic DNA codes polyhedrin which is a major protein of inclusion bodies and is mass-produced in infected silkworm larvae. We employed this polyhedrin production system to obtain a large yield of a foreign gene product. The coding region of the carboxy-terminal half of polyhedrin was removed and the remainder was ligated with the IGF II gene in phase to create a fusion protein gene consisting of the coding region of the amino-terminal half of polyhedrin and the IGF II gene. This fusion protein gene was combined in a plasmid with the promoter and 5' and 3' flanking regions of the polyhedrin gene. The resulting plasmid and the wild-type BmNPV genomic DNA were cotransfected into BM-N cells, and a recombinant virus was isolated by the limiting dilution method. The silkworm larvae infected with the recombinant virus produced 3.6 mg of the fusion protein per larva and the infected BM-N cells produced 0.3 mg per ml of culture. IGF II was released from the fusion protein produced by BM-N cells infected with the recombinant virus by CNBr treatment, purified by extraction with guanidine-HCl, column chromatography and HPLC and the correct amino-terminal amino acid sequence confirmed.

UI MeSH Term Description Entries
D007304 Insect Viruses Viruses infecting insects, the largest family being BACULOVIRIDAE. Insect Virus,Virus, Insect,Viruses, Insect
D007335 Insulin-Like Growth Factor II A well-characterized neutral peptide believed to be secreted by the LIVER and to circulate in the BLOOD. It has growth-regulating, insulin-like and mitogenic activities. The growth factor has a major, but not absolute, dependence on SOMATOTROPIN. It is believed to be a major fetal growth factor in contrast to INSULIN-LIKE GROWTH FACTOR I, which is a major growth factor in adults. IGF-II,Multiplication-Stimulating Activity,Somatomedin MSA,IGF-2,Insulin Like Growth Factor II,Insulin-Like Somatomedin Peptide II,Multiplication-Stimulating Factor,Somatomedin A,Factor, Multiplication-Stimulating,Insulin Like Somatomedin Peptide II,Multiplication Stimulating Activity,Multiplication Stimulating Factor
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004274 DNA, Recombinant Biologically active DNA which has been formed by the in vitro joining of segments of DNA from different sources. It includes the recombination joint or edge of a heteroduplex region where two recombining DNA molecules are connected. Genes, Spliced,Recombinant DNA,Spliced Gene,Recombinant DNA Research,Recombination Joint,DNA Research, Recombinant,Gene, Spliced,Joint, Recombination,Research, Recombinant DNA,Spliced Genes
D005814 Genes, Viral The functional hereditary units of VIRUSES. Viral Genes,Gene, Viral,Viral Gene
D005822 Genetic Vectors DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition. Cloning Vectors,Shuttle Vectors,Vectors, Genetic,Cloning Vector,Genetic Vector,Shuttle Vector,Vector, Cloning,Vector, Genetic,Vector, Shuttle,Vectors, Cloning,Vectors, Shuttle
D000077183 Occlusion Body Matrix Proteins Proteins that assemble into a crystalline polyhedral or ovicylindrical shape around insect viruses, including BACULOVIRIDAE and CYPOVIRUS. Granulin Matrix Proteins,Polyhedrin Matrix Proteins,Viral Granulin,Viral Granulin Proteins,Viral Occlusion Body Matrix Proteins,Viral Polyhedra Matrix Proteins,Viral Polyhedra Proteins,Viral Polyhedrin,Granulin Proteins, Viral,Granulin, Viral,Polyhedra Proteins, Viral,Polyhedrin, Viral
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Y Marumoto, and Y Sato, and H Fujiwara, and K Sakano, and Y Saeki, and M Agata, and M Furusawa, and S Maeda
August 1992, Bio/technology (Nature Publishing Company),
Y Marumoto, and Y Sato, and H Fujiwara, and K Sakano, and Y Saeki, and M Agata, and M Furusawa, and S Maeda
May 1985, Journal of virology,
Y Marumoto, and Y Sato, and H Fujiwara, and K Sakano, and Y Saeki, and M Agata, and M Furusawa, and S Maeda
February 1994, Journal of biochemistry,
Y Marumoto, and Y Sato, and H Fujiwara, and K Sakano, and Y Saeki, and M Agata, and M Furusawa, and S Maeda
January 1992, Bioscience, biotechnology, and biochemistry,
Y Marumoto, and Y Sato, and H Fujiwara, and K Sakano, and Y Saeki, and M Agata, and M Furusawa, and S Maeda
May 1996, Protein expression and purification,
Y Marumoto, and Y Sato, and H Fujiwara, and K Sakano, and Y Saeki, and M Agata, and M Furusawa, and S Maeda
October 1985, Scientia Sinica. Series B, Chemical, biological, agricultural, medical & earth sciences,
Y Marumoto, and Y Sato, and H Fujiwara, and K Sakano, and Y Saeki, and M Agata, and M Furusawa, and S Maeda
October 2008, Acta biochimica et biophysica Sinica,
Y Marumoto, and Y Sato, and H Fujiwara, and K Sakano, and Y Saeki, and M Agata, and M Furusawa, and S Maeda
January 1991, Journal of biochemistry,
Y Marumoto, and Y Sato, and H Fujiwara, and K Sakano, and Y Saeki, and M Agata, and M Furusawa, and S Maeda
May 2019, Journal of proteomics,
Y Marumoto, and Y Sato, and H Fujiwara, and K Sakano, and Y Saeki, and M Agata, and M Furusawa, and S Maeda
January 2005, Biochemical and biophysical research communications,
Copied contents to your clipboard!